{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:20:21Z","timestamp":1790619621057,"version":"4.1.0"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pharmthera.2023.108349","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:17:42Z","timestamp":1674181062000},"page":"108349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["From bench to clinic: Emerging therapies for corneal scarring"],"prefix":"10.1016","volume":"242","author":[{"given":"Gink N.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Ke","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Gardner-Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry A.","family":"Couper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dusting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daniell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11095-008-9818-6","article-title":"Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses","volume":"26","author":"Ali","year":"2009","journal-title":"Pharmaceutical Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192145","article-title":"KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis","volume":"13","author":"Anumanthan","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.survophthal.2012.01.009","article-title":"Lamellar corneal transplantation","volume":"57","author":"Arenas","year":"2012","journal-title":"Survey of Ophthalmology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1542-0124(12)70166-0","article-title":"Excimer laser phototherapeutic keratectomy","volume":"4","author":"Ayres","year":"2006","journal-title":"The Ocular Surface"},{"issue":"266","key":"10.1016\/j.pharmthera.2023.108349_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009644","article-title":"Human limbal biopsy-derived stromal stem cells prevent corneal scarring","volume":"6","author":"Basu","year":"2014","journal-title":"Science Translational Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108349_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ICL.0000000000000821","article-title":"Quality-of-life improvement after scleral Lens fitting in patients with keratoconus","volume":"47","author":"Baudin","year":"2021","journal-title":"Eye & Contact Lens"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0035","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.omtn.2020.07.032","article-title":"USP10 targeted self-deliverable siRNA to prevent scarring in the cornea","volume":"21","author":"Boumil","year":"2020","journal-title":"Molecular Therapy--Nucleic Acids"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0040","article-title":"Hydrogels as corneal stroma substitutes for in vitro evaluation of drug ocular permeation","volume":"14","author":"Burgalassi","year":"2022","journal-title":"Pharmaceutics [Internet]."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s42003-019-0316-7","article-title":"MG53 promotes corneal wound healing and mitigates fibrotic remodeling in rodents","volume":"2","author":"Chandler","year":"2019","journal-title":"Communications Biology."},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: An anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Survey of Ophthalmology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0055","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/aos.14704","article-title":"Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: A meta-analysis and trial sequential analysis","volume":"99","author":"Chang","year":"2021","journal-title":"Acta Ophthalmologica"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1167\/iovs.18-24869","article-title":"A novel tissue-engineered corneal stromal equivalent based on amniotic membrane and Keratocytes","volume":"60","author":"Che","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/iovs.16-20009","article-title":"Galectin-3 inhibition by a small-molecule inhibitor reduces both pathological corneal neovascularization and fibrosis","volume":"58","author":"Chen","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0070","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aa92d2","article-title":"Biomaterials for corneal bioengineering","volume":"13","author":"Chen","year":"2018","journal-title":"Biomedical Materials"},{"issue":"23","key":"10.1016\/j.pharmthera.2023.108349_bb0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000125","article-title":"Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis","volume":"93","author":"Cho","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biomaterials.2019.04.013","article-title":"A self-healing hydrogel eye drop for the sustained delivery of decorin to prevent corneal scarring","volume":"210","author":"Chouhan","year":"2019","journal-title":"Biomaterials."},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070528","article-title":"Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn","volume":"8","author":"Chowdhury","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0090","first-page":"329","article-title":"Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosis","volume":"10","author":"Chung","year":"2017","journal-title":"Int J Ophthalmol [Internet]"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0039-6257(04)00111-0","article-title":"Patient expectations for medical and surgical care: A review of the literature and applications to ophthalmology","volume":"49","author":"Dawn","year":"2004","journal-title":"Survey of Ophthalmology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/ICO.0000000000000754","article-title":"Randomized trial comparing amniotic membrane transplantation with lamellar corneal graft for the treatment of corneal thinning","volume":"35","author":"de Farias","year":"2016","journal-title":"Cornea."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0105","first-page":"29","article-title":"The efficacy of topical HGF on corneal fibrosis and epithelial healing after scar-producing PRK injury in rabbits. Transl Vis","volume":"9","author":"de Oliveira","year":"2020","journal-title":"Science and Technology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.9.12.1","article-title":"Therapeutic potential of extracellular vesicles for the treatment of corneal injuries and scars","volume":"9","author":"Deng","year":"2020","journal-title":"Translational Vision Science & Technology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0125","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.survophthal.2021.11.005","article-title":"Post-penetrating keratoplasty astigmatism","volume":"67","author":"Deshmukh","year":"2022","journal-title":"Survey of Ophthalmology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0130","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0b013e3181a4bbf2","article-title":"A contact Lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction","volume":"87","author":"Di Girolamo","year":"2009","journal-title":"Transplantation."},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108349_bb0135","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/stem.91","article-title":"Stem cell therapy restores transparency to defective murine corneas","volume":"27","author":"Du","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41598-021-04418-x","article-title":"Suppression of lipopolysaccharide-induced corneal opacity by hepatocyte growth factor","volume":"12","author":"Elbasiony","year":"2022","journal-title":"Scientific Reports"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108349_bb0145","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/bjophthalmol-2020-317464","article-title":"Ocular manifestations of congenital insensitivity to pain: A long-term follow-up","volume":"106","author":"Elsana","year":"2022","journal-title":"The British Journal of Ophthalmology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1034\/j.1600-0420.2003.00015.x","article-title":"Phototherapeutic keratectomy: 12 years of experience","volume":"81","author":"Fagerholm","year":"2003","journal-title":"Acta Ophthalmologica Scandinavica"},{"issue":"46","key":"10.1016\/j.pharmthera.2023.108349_bb0155","doi-asserted-by":"crossref","first-page":"46ra61","DOI":"10.1126\/scitranslmed.3001022","article-title":"A biosynthetic alternative to human donor tissue for inducing corneal regeneration: 24-month follow-up of a phase 1 clinical study","volume":"2","author":"Fagerholm","year":"2010","journal-title":"Science Translational Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0160","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.biomaterials.2013.11.079","article-title":"Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold","volume":"35","author":"Fagerholm","year":"2014","journal-title":"Biomaterials."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis (Lond)."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: A systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.23678","article-title":"Recessive mutations in the neuronal isoforms of DST, encoding dystonin, lead to abnormal actin cytoskeleton organization and HSAN type VI","volume":"40","author":"Fortugno","year":"2019","journal-title":"Human Mutation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0180","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Delivery and Translational Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmology."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0190","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2174\/1389450121666200319111710","article-title":"Anti-VEGF treatment in corneal diseases","volume":"21","author":"Giannaccare","year":"2020","journal-title":"Current Drug Targets"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0195","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0012-1606(88)90136-4","article-title":"Hemidesmosomes and anchoring fibril collagen appear synchronously during development and wound healing","volume":"126","author":"Gipson","year":"1988","journal-title":"Developmental Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0012-1606(88)90136-4","article-title":"Hemidesmosomes and anchoring fibril collagen appear synchronously during development and wound healing","volume":"126","author":"Gipson","year":"1988","journal-title":"Developmental Biology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0205","first-page":"2014","article-title":"Ocular manifestations in porphyria cutanea tarda","author":"Gogri","year":"2014","journal-title":"BML Case Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0210","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0161-6420(99)00134-7","article-title":"Intraocular foreign bodies: Management, prognostic factors, and visual outcomes","volume":"107","author":"Greven","year":"2000","journal-title":"Ophthalmology."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000346172","article-title":"Characterization of vitamin C-induced cell sheets formed from primary and immortalized human corneal stromal cells for tissue engineering applications","volume":"197","author":"Grobe","year":"2013","journal-title":"Cells, Tissues, Organs"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.burns.2018.08.021","article-title":"(\u2212)-Epigallocatechin-3-gallate, reduces corneal damage secondary from experimental grade II alkali burns in mice","volume":"45","author":"Gulias-Ca\u00f1izo","year":"2019","journal-title":"Burns."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172928","article-title":"Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo","volume":"12","author":"Gupta","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0230","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1167\/iovs.17-23308","article-title":"Novel combination BMP7 and HGF gene therapy instigates selective Myofibroblast apoptosis and reduces corneal haze in vivo","volume":"59","author":"Gupta","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0235","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.ymthe.2022.06.018","article-title":"Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo","volume":"30","author":"Gupta","year":"2022","journal-title":"Molecular Therapy"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0240","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhsa.2013.02.032","article-title":"How surgeons make decisions when the evidence is inconclusive","volume":"38","author":"Hageman","year":"2013","journal-title":"The Journal of Hand Surgery"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0245","volume":"22","author":"Han SBAUAVWCWAUNSRAUMJSTIGHi","year":"2021","journal-title":"International Journal of Molecular Sciences [Internet]."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/scrt226","article-title":"Characterization of corneal stromal stem cells with the potential for epithelial transdifferentiation","volume":"4","author":"Hashmani","year":"2013","journal-title":"Stem Cell Research & Therapy"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022079","article-title":"Transcriptional control by the SMADs","volume":"8","author":"Hill","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41536-018-0061-4","article-title":"Sustained release of decorin to the surface of the eye enables scarless corneal regeneration","volume":"3","author":"Hill","year":"2018","journal-title":"Npj Regenerative Medicine"},{"issue":"11\u221212","key":"10.1016\/j.pharmthera.2023.108349_bb0265","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1089\/ten.2005.11.1710","article-title":"Tissue engineering of nearly transparent corneal stroma","volume":"11","author":"Hu","year":"2005","journal-title":"Tissue Engineering"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125295","article-title":"Preclinical study of novel gene silencer pyrrole-imidazole polyamide targeting human TGF-\u03b21 promoter for hypertrophic scars in a common marmoset primate model","volume":"10","author":"Igarashi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0275","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-\u03b2 signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0280","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/APO.0000000000000326","article-title":"Surgical management of limbal stem cell deficiency","volume":"9","author":"Iyer","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108349_bb0285","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s11999-015-4304-z","article-title":"Do surgeons treat their patients like they would treat themselves?","volume":"473","author":"Janssen","year":"2015","journal-title":"Clinical Orthopaedics and Related Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108495","article-title":"Diseases of the corneal endothelium","volume":"205","author":"Jeang","year":"2021","journal-title":"Experimental Eye Research"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108349_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136980","article-title":"Combined therapy using human corneal stromal stem cells and quiescent Keratocytes to prevent corneal scarring after injury","volume":"23","author":"Jhanji","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10561-017-9618-5","article-title":"Amniotic membrane in ophthalmology: Properties, preparation, storage and indications for grafting-a review","volume":"18","author":"Jirsova","year":"2017","journal-title":"Cell and Tissue Banking"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082990","article-title":"A novel CD147 inhibitor, SP-8356, attenuates pathological fibrosis in alkali-burned rat cornea","volume":"21","author":"Joung","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0310","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/ICO.0000000000001231","article-title":"Corneal breakthrough haze after photorefractive keratectomy with mitomycin C: Incidence and risk factors","volume":"36","author":"Kaiserman","year":"2017","journal-title":"Cornea."},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archopht.117.5.649","article-title":"Effect of topical ascorbic acid on free radical tissue damage and inflammatory cell influx in the cornea after excimer laser corneal surgery","volume":"117","author":"Kasetsuwan","year":"1999","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0320","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2012.10.056","article-title":"Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery","volume":"103","author":"Katara","year":"2013","journal-title":"Colloids and Surfaces. B, Biointerfaces"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0325","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajhg.2018.11.017","article-title":"Mutations in NCAPG2 cause a severe neurodevelopmental syndrome that expands the phenotypic Spectrum of Condensinopathies","volume":"104","author":"Khan","year":"2019","journal-title":"American Journal of Human Genetics"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0330","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ophtha.2007.03.050","article-title":"A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy","volume":"114","author":"Khaw","year":"2007","journal-title":"Ophthalmology."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.intimp.2017.05.005","article-title":"Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model","volume":"48","author":"Kim","year":"2017","journal-title":"International Immunopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0340","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/ICU.0000000000000774","article-title":"Challenges in management of the Boston Keratoprosthesis type 1","volume":"32","author":"Koo","year":"2021","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0345","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000131087","article-title":"Surgery of the cornea: Corneal, limbal stem cell and amniotic membrane transplantation","volume":"41","author":"Kruse","year":"2008","journal-title":"Developments in Ophthalmology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0350","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ICL.0000000000000584","article-title":"Systematic review on therapeutic strategies to minimize corneal stromal scarring after injury","volume":"45","author":"Kwok","year":"2019","journal-title":"Eye & Contact Lens"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10875-020-00867-7","article-title":"JAK inhibition in a patient with X-linked reticulate pigmentary disorder","volume":"41","author":"L\u00e9geret","year":"2021","journal-title":"Journal of Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0360","doi-asserted-by":"crossref","first-page":"20841","DOI":"10.1038\/srep20841","article-title":"ITF2357 transactivates Id3 and regulate TGF\u03b2\/BMP7 signaling pathways to attenuate corneal fibrosis","volume":"6","author":"Lim","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0370","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Progress in Retinal and Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0375","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exer.2012.12.012","article-title":"Strategies for developing decellularized corneal scaffolds","volume":"108","author":"Lynch","year":"2013","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/805876","article-title":"Congenital corneal anesthesia and neurotrophic keratitis: Diagnosis and management","volume":"2015","author":"Mantelli","year":"2015","journal-title":"BioMed Research International"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0385","first-page":"189","article-title":"The challenge of patient adherence","volume":"1","author":"Martin","year":"2005","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0390","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.01.023","article-title":"Corneal regeneration: A review of stromal replacements","volume":"69","author":"Matthyssen","year":"2018","journal-title":"Acta Biomaterialia"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051080","article-title":"Extracellular vesicles secreted by corneal epithelial cells promote myofibroblast differentiation","volume":"9","author":"McKay","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.001","article-title":"Corneal structure and transparency","volume":"49","author":"Meek","year":"2015","journal-title":"Progress in Retinal and Eye Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0405","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-020-01403-x","article-title":"Emergency management in epidermolysis bullosa: Consensus clinical recommendations from the European reference network for rare skin diseases","volume":"15","author":"Mellerio","year":"2020","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0410","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/OPTH.S157430","article-title":"Recurrent corneal erosion: A comprehensive review","volume":"13","author":"Miller","year":"2019","journal-title":"Clinical Ophthalmology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0415","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13023-021-01901-6","article-title":"Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: Substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases","volume":"16","author":"Miller","year":"2021","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0420","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.stemcr.2016.09.001","article-title":"Restoration of corneal transparency by mesenchymal stem cells","volume":"7","author":"Mittal","year":"2016","journal-title":"Stem Cell Reports"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026432","article-title":"Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo","volume":"6","author":"Mohan","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0430","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jtos.2012.10.004","article-title":"Corneal gene therapy: Basic science and translational perspective","volume":"11","author":"Mohan","year":"2013","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108361","article-title":"Novel insights into gene therapy in the cornea","volume":"202","author":"Mohan","year":"2021","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0440","article-title":"Corneal stromal repair and regeneration","volume":"101090","author":"Mohan","year":"2022","journal-title":"Progress in Retinal and Eye Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0445","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 family: Context-dependent roles in cell and tissue physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0450","first-page":"CD008420","article-title":"Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy","author":"Nanavaty","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165464","article-title":"Derivation of corneal Keratocyte-like cells from human induced pluripotent stem cells","volume":"11","author":"Naylor","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0460","first-page":"479","article-title":"Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts","volume":"18","author":"Nelson","year":"2012","journal-title":"Molecular Vision"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0465","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2796.2000.00624.x","article-title":"The educated patient: New challenges for the medical profession","volume":"247","author":"Neuberger","year":"2000","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Experimental Eye Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108349_bb0475","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrm2466","article-title":"The promise of human induced pluripotent stem cells for research and therapy","volume":"9","author":"Nishikawa","year":"2008","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0480","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2147\/OPTH.S265136","article-title":"In vivo imaging of reis-B\u00fccklers and Thiel-Behnke corneal dystrophies using anterior segment optical coherence tomography","volume":"14","author":"Nishino","year":"2020","journal-title":"Clinical Ophthalmology"},{"issue":"7336","key":"10.1016\/j.pharmthera.2023.108349_bb0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/471046a","article-title":"Stem cells: The dark side of induced pluripotency","volume":"471","author":"Pera","year":"2011","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0490","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.86.4.397","article-title":"Corneal tattooing: An alternative treatment for disfiguring corneal scars","volume":"86","author":"Pitz","year":"2002","journal-title":"The British Journal of Ophthalmology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0495","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/ICO.0000000000002565","article-title":"Endothelial keratoplasty update 2020","volume":"40","author":"Price","year":"2021","journal-title":"Cornea."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0500","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1194\/jlr.M067264","article-title":"Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients","volume":"58","author":"Qi","year":"2017","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41420-018-0066-1","article-title":"BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring","volume":"4","author":"Qu","year":"2018","journal-title":"Cell Death Discovery."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10561-009-9128-1","article-title":"Serum eye drops, amniotic membrane and limbal epithelial stem cells--tools in the treatment of ocular surface disease","volume":"11","author":"Rauz","year":"2010","journal-title":"Cell and Tissue Banking"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0515","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/74447","article-title":"Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro","volume":"18","author":"Reubinoff","year":"2000","journal-title":"Nature Biotechnology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0520","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"The Ocular Surface"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13643-021-01704-7","article-title":"Effectiveness of matching human leukocyte antigens (HLA) in corneal transplantation: A systematic review protocol","volume":"10","author":"Sachdeva","year":"2021","journal-title":"Systematic Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0530","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SLA.0000000000001784","article-title":"Surgeon perception of risk and benefit in the decision to operate","volume":"264","author":"Sacks","year":"2016","journal-title":"Annals of Surgery"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0535","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ICU.0000000000000373","article-title":"The Boston keratoprosthesis","volume":"28","author":"Saeed","year":"2017","journal-title":"Current Opinion in Ophthalmology"},{"issue":"3 Suppl 1","key":"10.1016\/j.pharmthera.2023.108349_bb0540","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcjo.2019.08.007","article-title":"Patients\u2019 complaints involving ophthalmologists in the province of Ontario, Canada: A 5-year review","volume":"55","author":"Saha","year":"2020","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0545","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9440(10)62357-7","article-title":"Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice","volume":"166","author":"Saika","year":"2005","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0550","article-title":"Superficial keratectomy: A review of literature","volume":"9","author":"Salari","year":"2022","journal-title":"Frontiers in Medicine (Lausanne)."},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0555","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1167\/iovs.18-24803","article-title":"Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing","volume":"59","author":"Samaeekia","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108940","article-title":"Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet\u2019s membrane-endothelial excision in rabbits","volume":"216","author":"Sampaio","year":"2022","journal-title":"Experimental Eye Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0565","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICO.0b013e31821e429d","article-title":"Mitomycin C: Biological effects and use in refractive surgery","volume":"31","author":"Santhiago","year":"2012","journal-title":"Cornea."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0570","first-page":"2013","article-title":"Porphyria: Varied ocular manifestations and management","author":"Sati","year":"2013","journal-title":"BML Case Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0575","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jcrs.2017.08.024","article-title":"Vision-related quality of life and dependency in French keratoconus patients: Impact study","volume":"43","author":"Saunier","year":"2017","journal-title":"Journal of Cataract and Refractive Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0580","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ICO.0000000000002406","article-title":"Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty","volume":"40","author":"Schaub","year":"2021","journal-title":"Cornea."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0585","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.omtn.2019.07.017","article-title":"Effective in vivo topical delivery of siRNA and gene silencing in intact corneal epithelium using a modified cell-penetrating peptide","volume":"17","author":"Schiroli","year":"2019","journal-title":"Molecular Therapy--Nucleic Acids"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0590","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.icu.0000156139.05323.26","article-title":"Compliance and persistency in glaucoma follow-up treatment","volume":"16","author":"Schwartz","year":"2005","journal-title":"Current Opinion in Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0595","series-title":"Treasure Island (FL): StatPearls publishing copyright \u00a9 2022","article-title":"StatPearls","author":"Shah","year":"2022"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0600","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/ICU.0b013e32833a8c9b","article-title":"Use of mitomycin-C for phototherapeutic keratectomy and photorefractive keratectomy surgery","volume":"21","author":"Shah","year":"2010","journal-title":"Current Opinion in Ophthalmology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0605","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1203\/PDR.0b013e31816bdf54","article-title":"The development of a tissue-engineered cornea: Biomaterials and culture methods","volume":"63","author":"Shah","year":"2008","journal-title":"Pediatric Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108349_bb0610","article-title":"Nox4 facilitates TGF\u03b21-induced fibrotic response in human Tenon\u2019s fibroblasts and promotes wound collagen accumulation in murine model of Glaucoma filtration surgery","volume":"9","author":"Shah","year":"2020","journal-title":"Antioxidants (Basel)."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0615","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2229-5178.93505","article-title":"Keratitis-ichthyosis-deafness syndrome: A rare congenital disorder","volume":"3","author":"Shanker","year":"2012","journal-title":"Indian Dermatology Online Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0620","doi-asserted-by":"crossref","first-page":"E371","DOI":"10.1208\/aapsj0903044","article-title":"Preparation and ocular pharmacokinetics of ganciclovir liposomes","volume":"9","author":"Shen","year":"2007","journal-title":"The AAPS Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108349_bb0625","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1167\/iovs.13-11684","article-title":"Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-\u03b21\/ERK pathways regulation","volume":"54","author":"Shin","year":"2013","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0630","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/bmb\/ldr041","article-title":"Corneal stem cells in the eye clinic","volume":"100","author":"Shortt","year":"2011","journal-title":"British Medical Bulletin"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0635","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jtos.2019.07.005","article-title":"Therapeutic efficacy of different routes of mesenchymal stem cell administration in corneal injury","volume":"17","author":"Shukla","year":"2019","journal-title":"The Ocular Surface"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0640","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s42399-020-00292-2","article-title":"Pharmacological treatment of fibrosis: A systematic review of clinical trials","volume":"2","author":"Siani","year":"2020","journal-title":"SN Comprehensive Clinical Medicine."},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0645","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1111\/jcmm.15168","article-title":"Acetylcholine decreases formation of myofibroblasts and excessive extracellular matrix production in an in vitro human corneal fibrosis model","volume":"24","author":"S\u0142oniecka","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108349_bb0650","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1167\/iovs.13-12758","article-title":"Triple combination of siRNAs targeting TGF\u03b21, TGF\u03b2R2, and CTGF enhances reduction of collagen I and smooth muscle actin in corneal fibroblasts","volume":"54","author":"Sriram","year":"2013","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108349_bb0655","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nature Clinical Practice. Rheumatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0660","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15586","article-title":"Evolution of the skin manifestations of X-linked pigmentary reticulate disorder","volume":"177","author":"Starokadomskyy","year":"2017","journal-title":"The British journal of dermatology."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0665","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0028-3886.338691","article-title":"Hereditary sensory and autonomic neuropathy: A case series of six children","volume":"70","author":"Suthar","year":"2022","journal-title":"Neurology India"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0670","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0675","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrm.2016.8","article-title":"A decade of transcription factor-mediated reprogramming to pluripotency","volume":"17","author":"Takahashi","year":"2016","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0680","doi-asserted-by":"crossref","first-page":"332","DOI":"10.47102\/annals-acadmedsg.V38N4p332","article-title":"Paradigm shifts in corneal transplantation","volume":"38","author":"Tan","year":"2009","journal-title":"Annals of the Academy of Medicine, Singapore"},{"issue":"9827","key":"10.1016\/j.pharmthera.2023.108349_bb0685","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","article-title":"Corneal transplantation","volume":"379","author":"Tan","year":"2012","journal-title":"Lancet."},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2012.01.003","article-title":"Osteo-odonto keratoprosthesis: Systematic review of surgical outcomes and complication rates","volume":"10","author":"Tan","year":"2012","journal-title":"The Ocular Surface"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066434","article-title":"BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo","volume":"8","author":"Tandon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121320","article-title":"Exosomes-loaded thermosensitive hydrogels for corneal epithelium and stroma regeneration","volume":"280","author":"Tang","year":"2022","journal-title":"Biomaterials."},{"issue":"5391","key":"10.1016\/j.pharmthera.2023.108349_bb0705","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0710","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2014.09.013","article-title":"Cellular and extracellular matrix modulation of corneal stromal opacity","volume":"129","author":"Torricelli","year":"2014","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0715","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.exer.2014.09.012","article-title":"The corneal fibrosis response to epithelial-stromal injury","volume":"142","author":"Torricelli","year":"2016","journal-title":"Experimental Eye Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108349_bb0720","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/ICO.0000000000002374","article-title":"Corneal blindness in Asia: A systematic review and meta-analysis to identify challenges and opportunities","volume":"39","author":"Tran","year":"2020","journal-title":"Cornea."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0725","first-page":"7","article-title":"Recent developments in bioprocessing of recombinant proteins: Expression hosts and process development","author":"Tripathi","year":"2019","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0730","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrm.2016.10","article-title":"Pluripotent stem cells progressing to the clinic","volume":"17","author":"Trounson","year":"2016","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0735","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.2001.00363.x","article-title":"Patient adherence to treatment: Three decades of research. A comprehensive review","volume":"26","author":"Vermeire","year":"2001","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0740","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3389\/fphar.2019.01661","article-title":"Proteoglycans in biomedicine: Resurgence of an underexploited class of ECM molecules","volume":"10","author":"Walimbe","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0745","article-title":"Immunological properties of corneal epithelial-like cells derived from human embryonic stem cells","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0750","first-page":"214","article-title":"Corneal blindness: A global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0755","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/ceo.14089","article-title":"Outcomes of corneal transplantation in Australia, in an era of lamellar keratoplasty","volume":"50","author":"Williams","year":"2022","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108272","article-title":"Corneal myofibroblasts and fibrosis","volume":"201","author":"Wilson","year":"2020","journal-title":"Experimental Eye Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0765","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.4.8","article-title":"Interleukin-1 and transforming growth factor Beta: Commonly opposing, but sometimes supporting, master regulators of the corneal wound healing response to injury","volume":"62","author":"Wilson","year":"2021","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020309","article-title":"Fibrosis is a basement membrane-related disease in the cornea: Injury and defective regeneration of basement membranes may underlie fibrosis in other organs","volume":"11","author":"Wilson","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.pharmthera.2023.108349_bb0775","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.matbio.2017.06.003","article-title":"Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: A paradigm for fibrosis in other organs?","volume":"64","author":"Wilson","year":"2017","journal-title":"Matrix Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0780","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3928\/1081597X-20161123-01","article-title":"Phototherapeutic keratectomy: Science and art","volume":"33","author":"Wilson","year":"2017","journal-title":"Journal of Refractive Surgery"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0785","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.63.1.22","article-title":"Corneal opacity: Cell biological determinants of the transition from transparency to transient haze to scarring fibrosis, and resolution, after injury","volume":"63","author":"Wilson","year":"2022","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0790","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-022-02444-8","article-title":"The effect of topical decorin on temporal changes to corneal immune cells after epithelial abrasion","volume":"19","author":"Wu","year":"2022","journal-title":"Journal of Neuroinflammation"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0795","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"The Journal of Clinical Investigation."},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108349_bb0800","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1167\/iovs.17-23575","article-title":"Safety and feasibility of intrastromal injection of cultivated human corneal stromal Keratocytes as cell-based therapy for corneal opacities","volume":"59","author":"Yam","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108349_bb0805","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-4835(02)00293-2","article-title":"Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury","volume":"76","author":"Yamada","year":"2003","journal-title":"Experimental Eye Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0810","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1167\/iovs.08-2282","article-title":"Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor gamma gene transfer in mice","volume":"50","author":"Yamanaka","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108349_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/biom11111682","article-title":"FAK inhibition attenuates corneal fibroblast differentiation in vitro","volume":"11","author":"Yeung","year":"2021","journal-title":"Biomolecules."},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108349_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115921","article-title":"Extracellular vesicles in corneal fibrosis\/scarring","volume":"23","author":"Yeung","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0825","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063136","article-title":"Extracellular vesicles secreted by corneal Myofibroblasts promote corneal epithelial cell migration","volume":"23","author":"Yeung","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108349_bb0830","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/08820538.2017.1353834","article-title":"Limbal stem cell transplantation and complications","volume":"33","author":"Yin","year":"2018","journal-title":"Seminars in Ophthalmology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0835","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1167\/iovs.04-1263","article-title":"Human corneal endothelial cell precursors isolated by sphere-forming assay","volume":"46","author":"Yokoo","year":"2005","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2023.108349_bb0840","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","article-title":"Nanotechnology for protein delivery: Overview and perspectives","volume":"240","author":"Yu","year":"2016","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108349_bb0845","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00517.2020","article-title":"LRG1 facilitates corneal fibrotic response by inducing neutrophil chemotaxis via Stat3 signaling in alkali-burned mouse corneas","volume":"321","author":"Yu","year":"2021","journal-title":"American Journal of Physiology. Cell Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108349_bb0850","first-page":"382","article-title":"Ascorbate prophylaxis with mitomycin-C for corneal haze after laser-assisted sub-epithelial keratectomy","volume":"14","author":"Yulish","year":"2012","journal-title":"The Israel Medical Association Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108349_bb0855","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3129\/i10-090","article-title":"Nanotechnology in ophthalmology","volume":"45","author":"Zarbin","year":"2010","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0860","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/ICU.0000000000000388","article-title":"The osteo-odonto-keratoprosthesis","volume":"28","author":"Zarei-Ghanavati","year":"2017","journal-title":"Current Opinion in Ophthalmology"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108349_bb0865","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1016\/j.bioactmat.2021.04.032","article-title":"A long-term retaining molecular coating for corneal regeneration","volume":"6","author":"Zhang","year":"2021","journal-title":"Bioactive Materials."},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108349_bb0870","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/dna.2021.1034","article-title":"The long noncoding RNA LINC00963 inhibits corneal fibrosis scar formation by targeting miR-143-3p","volume":"41","author":"Zhang","year":"2022","journal-title":"DNA and Cell Biology"},{"issue":"8\u20139","key":"10.1016\/j.pharmthera.2023.108349_bb0875","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1387\/ijdb.041860jz","article-title":"Corneal development associated with eyelid opening","volume":"48","author":"Zieske","year":"2004","journal-title":"The International Journal of Developmental Biology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582300013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582300013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:26:58Z","timestamp":1759012018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582300013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":175,"alternative-id":["S016372582300013X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108349","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From bench to clinic: Emerging therapies for corneal scarring","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108349"}}